Key Takeaways A new randomized trial tested injecting mesenchymal stem cells into the spinal fluid of 18 people with progressive MS. The trial’s main measure of nerve repair did not improve. The result was not statistically significant. Some secondary signals looked promising at six months but faded by twelve months.
Key Takeaways The realistic goals of stem cell therapy for MS are slowing disease activity, reducing fatigue, and improving mobility, not reversing all past damage. Mesenchymal stem cells (MSCs) calm the immune system and protect nerve fibers. Hematopoietic stem cell transplant (HSCT) goes further, aiming to reset the immune system
Quick Summary Mesenchymal stem cells (MSCs) help regulate immune responses in relapsing-remitting MS by interacting with immune cells, reducing inflammation, and providing neuroprotective effects. Unlike traditional immunosuppressive treatments, MSCs promote balanced immune modulation and may offer long-term stability with a favorable safety profile. How MSCs work: Interact with T cells
